GLIPIQ 8mg Injection may be prescribed for:

• Long-term weight management: It may be used in adults with obesity, defined as a body mass index (BMI) of 30 kg/m² or more.

• Overweight with weight-related health problems: It may be used in adults with a BMI of 27 kg/m² or more who have conditions such as type 2 diabetes, high blood pressure, or high cholesterol.

GLIPIQ should be used along with a suitable diet and regular physical activity. The dose is selected and adjusted by the doctor based on the individual's response and treatment plan.

Semaglutide works similarly to the natural hormone GLP-1, which is involved in appetite regulation and food intake. It acts on areas of the brain involved in appetite control, helping increase feelings of fullness and reduce food intake.

It also slows stomach emptying, which can help prolong feelings of fullness after eating. These effects can support weight management when GLIPIQ is used along with a reduced-calorie diet and increased physical activity.

Tell your doctor about all medicines, supplements, and herbal products you are taking before starting GLIPIQ 8mg Injection.

• Insulin and sulfonylureas: Semaglutide can increase the risk of low blood sugar when used with insulin or medicines such as sulfonylureas. Your doctor may adjust the dose of these medicines.

• Medicines taken by mouth: Semaglutide delays gastric emptying and may affect the absorption of some oral medicines.

• Other weight-management medicines: Do not combine GLIPIQ with other Semaglutide-containing medicines, GLP-1 receptor agonists, or other weight-management injections unless advised by your doctor.

• Medicines requiring careful monitoring: Tell your doctor about medicines such as warfarin or other medicines where changes in body weight, food intake, or gastrointestinal symptoms could affect treatment.

• Store GLIPIQ 8mg Injection in a refrigerator at 2°C to 8°C.

• Do not freeze.

• Protect the medicine from light.

• Keep out of reach of children.

• Follow the storage period and conditions stated on the product packaging after first use.

These storage instructions should be followed according to the GLIPIQ product packaging.

GLIPIQ 8mg Injection is given once weekly as a subcutaneous injection, exactly as prescribed by your doctor. It can be injected into the abdomen, thigh, or upper arm. Rotate the injection site when possible.

Your doctor or healthcare professional should show you how to use the injection correctly before your first dose. It can be administered with or without food. Use GLIPIQ on the same day each week as advised by your doctor.

Common side effects of GLIPIQ 8mg Injection may include:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Abdominal pain

• Indigestion

• Headache

• Fatigue

• Bloating or gas

These effects are more common when treatment is started or the dose is increased and may improve as the body adjusts.

Seek medical attention if you develop severe or persistent abdominal pain, especially if it spreads to the back, as this may be a sign of pancreatitis. Contact your doctor if you develop symptoms that may indicate gallbladder problems, kidney problems, or a serious allergic reaction.

• Use GLIPIQ 8mg Injection once weekly on the day prescribed by your doctor.

• Do not increase the dose or change the weekly schedule on your own.

• Follow the reduced-calorie diet and physical activity plan recommended by your healthcare professional.

• Rotate the injection site between the abdomen, thigh, and upper arm.

• Eat smaller meals if you experience nausea or early fullness.

• Drink enough fluids, particularly if vomiting or diarrhoea occurs.

• Tell your doctor if you have a history of pancreatitis, gallbladder problems, kidney disease, or severe gastrointestinal problems.

• If you use insulin or a sulfonylurea, learn the symptoms of low blood sugar and follow your doctor's advice on monitoring.